Coca-Cola launched the soda brand in the 1990s to compete with Mountain Dew. Sales didn't exactly take off.
VIDEO ON MSN MONEY
The Internet search company sues Facebook, alleging patent infringement. The clothing retailer reports weaker-than-expected quarterly results.
Updated at 8:40 a.m. ET
Yahoo (YHOO) filed a lawsuit against its partner Facebook, accusing the social network of patent infringement. The lawsuit, filed in federal court in San Jose, details patents related to messaging, social networking, privacy, customization and advertising. "Yahoo has invested substantial resources in research and development through the years, which has resulted in numerous patented inventions of technology that other companies have licensed," said a Yahoo spokesman. Facebook expressed surprise at Yahoo's legal action. "We will defend ourselves vigorously against these puzzling actions," a Facebook spokesman said.
Urban Outfitters (URBN) reported fourth-quarter earnings of 27 cents a share on revenue of $731 million. Analysts polled by Thomson Reuters, on average, were expecting the company to have earned 29 cents on revenue of $741.35 million.
Will the popular retailer be able to overcome this divide?
The alliance of luxury-goods producer Tiffany (TIF) and Swiss watchmaker Swatch looked, on the surface, like a match made in heaven. But the play-by-play reads like that of a failed marriage between a billionaire and a wealthy socialite.
Swatch needed a bit of a freshen up, and Tiffany's was happy to help in 2007. But scratching under the surface showed more than a little trouble in paradise. The main aim of the alliance was to develop, produce and globally distribute Tiffany brand watches. Swatch, of course, has plenty of experience in that area. Sadly, the wheels soon fell off the bus.
Investors looking for a way to play the new iPad should look beyond Apple to the two broadband service providers supporting iPad functionality.
Another season, another Apple product debut.
This spring's new Apple gizmo -- almost certain to generate still more cash for a company already sitting on nearly $100 billion -- is the next version of the iPad. The device will start shipping Friday, and Apple (AAPL) devotees will doubtless begin lining up at stores and camping out on sidewalks to be among the first to get their mitts on the new tablet.
The average listener is spending more time with Pandora, and that bodes well for advertising-revenue growth.
Pandora Media's (P) stock price tumbled 25% last week when the company announced disappointing earnings and a less-than-rosy outlook.
But let's shift our focus away from the miss to the actual fundamentals driving the business. Revenue and subscriber growth have been stellar, but costs -- especially content costs -- are growing at a higher rate.
Below, we take a quick look at what the growth metrics tell us.
Gas-station operators might be persuaded to install this natural-gas option from Chesapeake and GE.
Chesapeake Energy (CHK) and General Electric (GE) have partnered to bring natural-gas fueling to gas stations and convenience stores. This collaboration will combine GE's technology know-how with Chesapeake's expertise in developing fueling solutions.
Chesapeake Energy operates in the natural gas and oil production domain and also owns midstream and other oilfield assets in compression, drilling, trucking and pressure pumping.
Looking at related industries pulls up names that are almost as attractive.
Tech fund manager Ian Warmerdam says there are plenty of areas within the broader sector that have delivered gains. In Monday's interview with MoneyShow.com, he shares a few more techs with valuations at attractive levels, despite recent rallies.
Kate Stalter: Today's guest is Ian Warmerdam. He is the director of technology investments and a portfolio manager at the Henderson Global Technology Fund (HFGAX). Ian, most people associate tech with growth, of course. Is that, indeed, among your fund's objectives?
The Federal Reserve may give some banks the green light to increase shareholder payouts.
CEO Iger wants the company to learn from the box-office mistake. But is this one mistake too many?
Walt Disney (DIS) CEO Bob Iger is trying to transform its huge box-office bomb "John Carter"into a teachable moment where nobody will lose their jobs. What a pity.
There's plenty of blame to go around for this turkey of a sci-fi mega-flick, as The New York Times notes. First, the script -- based on a forgotten story by Tarzan creator Edgar Rice Burroughs -- was a mess.
Will the company drop the Queen of Southern Cuisine because of new allegations of offensive remarks?
Novo Nordisk (NVO) is having Paula Deen trouble again. And this time it may not be as easy to explain away.
The company suffered a backlash less than two months ago for hiring the Southern belle as the public face of its new online program, Diabetes in a New Light. And just when the controversy was calming down, Deen and her brother were accused last week of racial and sexual harassment and abusive treatment by a former employee, Lisa Jackson.
Deen and her lawyers adamantly deny the charges, saying Jackson has pledged to ruin Deen's reputation if not paid a large sum of money.
The company is running 2 to 3 weeks behind on orders for the new tablet.
If you didn't preorder one for that date, you'll have to wait in line at an Apple retail store. And those queues can be obnoxious. Two people spent 17 days in line for the iPhone 4S debut last year. People are already lining up for Friday's launch, according to reports.
Apple's site shows a shipping delay time of two to three weeks for all three iPad models with Wi-Fi connectivity: the 16GB version for $499, the 32GB version for $599 and the 64 GB version for $699. There's a similar wait for the more expensive models with 4G connections.
After a sharp drop in its stock price, the world's largest security logistics system is attracting some attention.
Brink's (BCO) is the oldest and largest global provider of secure transportation for cash and other valuables. The company that was founded in 1859 is now attracting fresh attention from some large investors.
A recent big drop in its stock price has caught their eye.
A couple plays on a housing recovery have hit new highs, alongside a familiar aerospace supplier.
By Igor Greenwald, MoneyShow.com
One of the many joys of writing about the stock market is the sheer impossibility of acquiring expert up-to-date knowledge about more than a tiny fraction of the companies and industries it represents.
I can't possibly know how well Acme Widget's products are selling right now, scientifically evaluate the promise of the compound Elixir Labs is developing, and gauge the effect of recent accounting changes on Multilevel Marketing Inc's bottom line.
Changing technology trends that favor the PC maker's competitors only add to its woes.
Wherever I go, whatever story I read, Hewlett-Packard (HPQ) always seems to be on the short end of the stick. I recently looked at IBM (IBM), Accenture (ACN) and SAP (SAP), all of which are doing so well, and I have to conclude that they are simply carving up Hewlett-Packard's consulting business.
Then there is the $10 billion acquisition of Autonomy to boost the enterprise consulting business by offering search software. Having seen SAP's search software in action, I have no idea how Autonomy can compete. Must have some clients, I guess, but SAP is gunning for what HP has left.
These companies are making advances in medical treatments that target an individual's genetic profile.
One of the most exciting -- and potentially lucrative -- trends in the biotech sector is the emergence of personalized medicine. Advances in gene sequencing have enabled researchers to identify the root causes of chronic diseases. These discoveries, in turn, allow drug makers to develop targeted treatments, with less damaging side effects, for a number of illnesses.
The concept behind personalized medicine is simple: Based on genetic information medical practitioners can tailor health care solutions to individual patients. Here are three stocks poised to benefit from this trend: Qiagen (QGEN), Life Technologies (LIFE) and Roche Holding (RHHBY).
Shares of the embattled beverage maker have barely budged since she took the helm, while rival Coca-Cola's have soared.
MORE ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
Stocks drift lower and bonds are hit as investors await the Fed. Prepare for higher volatility this week.
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.
More Market News
|There’s a problem getting this information right now. Please try again later.|